Quantitative abnormalities of fetal trophoblast cells in maternal circulation in preeclampsia

Prenatal Diagnosis

Volumn 28, Issue 12, 2008, Pages 1160-1166

  Zhang, Ling ^a   Wang, Yan ^a   Liao, Ai Hua ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NONE   (China)

Author keywords

Circulating fetal trophoblast cells; HLA G; Preeclampsia; Prenatal diagnosis

Indexed keywords

HLA G ANTIGEN; TESTIS DETERMINING FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MATERNAL BLOOD; PREECLAMPSIA; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SEX DETERMINATION; SRY GENE; TROPHOBLAST;

BLOOD CELL COUNT; BLOOD CIRCULATION; CELL SEPARATION; CONGENITAL ABNORMALITIES; FEMALE; GESTATIONAL AGE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MATERNAL-FETAL EXCHANGE; PRE-ECLAMPSIA; PREGNANCY; PRENATAL DIAGNOSIS; SEX DETERMINATION (ANALYSIS); SOXB1 TRANSCRIPTION FACTORS; TROPHOBLASTS;

EID: 57149111960     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2135     Document Type: Article

References (34)

1. Aali BS, Malekpour R, Sedig F, Safa A. 2007. Comparison of maternal and cord blood nucleated red blood cell count between preeclamptic and healthy women. J Obstet Gynaecol Res 33: 274-278.
2. Al-Mufti R, Hambley H, Albaiges G, Lees C, Nicolaides KH. 2000. Increased fetal erythroblasts in women who subsequently develop pre-eclampsia. Hum Reprod 15: 1624-1628.
3. Banzola I, Farina A, Concu M, et al. 2007. Performance of a panel of maternal serum markers in predicting preeclampsia at 11-15 weeks' gestation. Prenat Diagn 27: 1005-1010.
4. Chen HP, Wang TR, Xu JP, et al. 2004. Comparison of three methods for the gene analysis of fetal cells from maternal peripheral blood. Chin Med J (Engl) 117: 507-510.
5. Farina A, Sekizawa A, Purwosunu Y, et al. 2006. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls. Prenat Diagn 26: 1115-1120.
6. Fernández A, Prieto B, Escudero A, Ladenson JH, Alvarez FV. 2005. A monoclonal antibody with potential for aiding non-invasive prenatal diagnosis: utility in screening of pregnant women at risk of preeclampsia. J Histochem Cytochem 53: 345-350.
7. Fujito N, Samura O, Miharu N, Tanigawa M, Hyodo M, Kudo Y. 2006. Increased plasma mRNAs of placenta-specific 1 (PLAC1) and glial cells-missing 1 (GCM1) in mothers with pre-eclampsia. Hiroshima J Med Sci 55: 9-15.
8. Guetta E, Gordon D, Simchen MJ, Goldman B, Barkai G. 2003. Hematopoietic progenitor cells as targets for non-invasive prenatal diagnosis: detection of fetal CD34+ cells and assessment of post-delivery persistence in the maternal circulation. Blood Cells Mol Dis 30: 13-21.
9. Guetta E, Gutstein-Abo L, Barkai G. 2005. Trophoblasts isolated from the maternal circulation: in vitro expansion and potential application in non-invasive prenatal diagnosis. J Histochem Cytochem 53: 337-339.
10. Guetta E, Simchen MJ, Mammon-Daviko K, et al. 2004. Analysis of fetal blood cells in the maternal circulation: challenges, ongoing efforts, and potential solutions. Stem Cells Dev 13: 93-99.
11. Hahn S, Holzgreve W. 2002a. Prenatal diagnosis using fetal cells and cell-free fetal DNA in maternal blood: what is currently feasible? Clin Obstet Gynecol 45: 649-656.
12. Hahn S, Holzgreve W. 2002b. Fetal cells and cell-free fetal DNA in maternal blood: new insights into pre-eclampsia. Hum Reprod Update 8: 501-508.
13. Heimrath J, Krawczenko A, Kozlak J, Dus D. 2004. Trophoblasts and soluble adhesion molecules in peripheral blood of women with pregnancy-induced hypertension. Am J Reprod Immunol 51: 152-155.
14. Holzgreve W, Ghezzi F, Di Naro E, Gänshirt D, Maymon E, Hahn S. 1998. Disturbed feto-maternal cell traffic in preeclampsia. Obstet Gynecol 91: 669-672.
15. Holzgreve W, Hahn S. 1999. Novel molecular biological approaches for the diagnosis of preeclampsia. Clin Chem 45: 451-452.
16. Jansen MW, Korver-Hakkennes K, van Leenen D, et al. 2001. Significantly higher number of fetal cells in the maternal circulation of women with pre-eclampsia. Prenat Diagn 21: 1022-1026.
17. Little MT, Langlois S, Wilson RD, Lansdorp PM. 1997. Frequency of fetal cells in sorted subpopulations of nucleated erythroid and CD34+ hematopoietic progenitor cells from maternal peripheral blood. Blood 89: 2347-2358.
18. Lo YM, Leung TN, Tein MS, et al. 1999. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 45: 184-188.
19. Loke YW, Hiby S, King A. 1999. Human leucocyte antigen-G and reproduction. J Reprod Immunol 43: 235-242.
20. Mueller UW, Hawes CS, Wright AE, et al. 1990. Isolation of fetal trophoblast cells from peripheral blood of pregnant women. Lancet 336: 197-200.
21. Ng EK, Leung TN, Tsui NB, et al. 2003b. The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. Clin Chem 49: 727-731.
22. Ng EK, Tsui NB, Lau TK, et al. 2003a. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 100: 4748-4753.
23. Oudejans CB, Tjoa ML, Westerman BA, Mulders MA, van Wijk IJ, Van Vugt JM. 2003. Circulating trophoblast in maternal blood. Prenat Diagn 23: 111-116.
24. Polakova K, Kuba D, Russ G. 2004. The 4H84 monoclonal antibody detecting beta2m free nonclassical HLA-G molecules also binds to free heavy chains of classical HLA class I antigens present on activated lymphocytes. Hum Immunol 65: 157-162.
25. Purwosunu Y, Sekizawa A, Farina A, et al. 2007. Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia. Prenat Diagn 27: 772-777.
26. Sekizawa A, Kimura T, Sasaki M, Nakamura S, Kobayashi R, Sato T. 1996. Prenatal diagnosis of Duchenne muscular dystrophy using a single fetal nucleated erythrocyte in maternal blood. Neurology 46: 1350-1353.
27. Swinkels DW, de Kok JB, Hendriks JC, Wiegerinck E, Zusterzeel PL, Steegers EA. 2002. Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum. Clin Chem 48: 650-653.
28. Tjoa ML, Delli-Bovi L, Johnson KL, Bianchi DW. 2007. Antibodies to trophoblast antigens HLA-G, placenta growth factor, and neuroD2 do not improve detection of circulating trophoblast cells in maternal blood. Fetal Diagn Ther 22: 85-89.
29. Van Lierop MJ, Wijnands F, Loke YW, et al. 2002. Detection of HLA-G by a specific sandwich ELISA using monoclonal antibodies G233 and 56B. Mol Hum Reprod 8: 776-784.
30. van Wijk IJ, Griffioen S, Tjoa ML, et al. 2001. HLA-G expression in trophoblast cells circulating in maternal peripheral blood during early pregnancy. Am J Obstet Gynecol 184: 991-997.
31. van Wijk IJ, van Vugt JM, Mulders MA, Könst AA, Weima SM, Oudejans CB. 1996. Enrichment of fetal trophoblast cells from the maternal peripheral blood followed by detection of fetal deoxyribonucleic acid with a nested X/Y polymerase chain reaction. Am J Obstet Gynecol 174: 871-878.
32. Vona G, Béroud C, Benachi A, et al. 2002. Enrichment, immunomorphological, and genetic characterization of fetal cells circulating in maternal blood. Am J Pathol 160: 51-58.
33. Zhang L, Cui X, Schmitt K, Hubert R, Navidi W, Arnheim N. 1992. Whole genome amplification from a single cell: implications for genetic analysis. Proc Natl Acad Sci U S A 89: 5847-5851.
34. Zhong XY, Gebhardt S, Hillermann R, Tofa KC, Holzgreve W, Hahn S. 2005. Parallel assessment of circulatory fetal DNA and corticotropin-releasing hormone mRNA in early- and late-onset preeclampsia. Clin Chem 51: 1730-1733.